Structured Product Labeling has been mandated by US FDA which is the only accepted method for electronic submission of drug labeling content for original submissions, supplements and annual reports.
SPL has also started to exchange information needed for other submissions such as Drug Listings, Establishment Registration (ER) and GDUFA Self Registration – now called as eDRL (electronic Drug (Establishment) Registration and (Product) Listing).
This approach is practical and effective in order to streamline submissions for pharmaceutical companies and its marketing within USA. Technically, an SPL is a schema governed electronic document based on the HL7’s (Health Level Seven) Clinical Document Architecture (CDA).
Sarjen pharma team creates and manages Structure Product Labeling (SPL) in XML form by using all the standard parameter as per US FDA requirement with 95% validation guarantee with prompt service.